reactogenicity
Showing 26 - 50 of 1,502
COVID-19 Trial (GBP510 adjuvanted with AS03, Placebo (Normal Saline))
Not yet recruiting
- COVID-19
- GBP510 adjuvanted with AS03
- Placebo (Normal Saline)
- (no location specified)
Aug 11, 2022
Vaccine Reaction, COVID-19, Children, Only Trial in Bukit Timah (BNT162b2 Pfizer-BioNTech/Comirnaty)
Recruiting
- Vaccine Reaction
- +2 more
- BNT162b2 Pfizer-BioNTech/Comirnaty
-
Bukit Timah, SingaporeKK Women's and Children's Hospital
Apr 25, 2022
Influenza, Human Trial (Flu mRNA, Control 1, Control 2)
Not yet recruiting
- Influenza, Human
- Flu mRNA
- +2 more
- (no location specified)
Apr 21, 2023
Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta
Not yet recruiting
- Vaccine Reaction
- COVID-19
- Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
- VidPrevtyn® Beta vaccine (Sanofi/GSK)
-
Paris, FranceCIC 1417 Cochin-Pasteur
Feb 28, 2023
Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)
Active, not recruiting
- Influenza, Human
- GSK4382276A Dose level 1
- +4 more
-
Edegem, Belgium
- +6 more
Jan 9, 2023
COVID-19 Trial in Johannesburg (AAHI-SC2 Vaccine, AAHI-SC3 Vaccine, EUA or approved vaccine)
Recruiting
- COVID-19
- AAHI-SC2 Vaccine
- +2 more
-
Johannesburg, South AfricaWits Vida
Jan 4, 2023
SARS-CoV-2 Trial in United States (mRNA-1283, mRNA-1273, Placebo)
Active, not recruiting
- SARS-CoV-2
- mRNA-1283
- +2 more
-
Chandler, Arizona
- +4 more
Sep 22, 2022
COVID-19 Trial in Shanghai, Beijing (Vaccine, COVID19)
Active, not recruiting
- COVID-19
- Vaccine, COVID19
-
Shanghai, Jingan, China
- +1 more
Feb 12, 2022
COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)
Not yet recruiting
- COVID-19 Infection
- COVID-19 Vaccine Adverse Reaction
- LEM-mR203
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital Clinical Trials Center
Sep 12, 2023
Haemophilus Influenzae Infection, Vaccines Trial in Koltsovo (Vaccine for the prevention of infections caused by Haemophilus
Completed
- Haemophilus Influenzae Infection
- Vaccines
- Vaccine for the prevention of infections caused by Haemophilus influenza type b
- Placebo
-
Koltsovo, Russian FederationFederally Funded Healthcare Institution Primary Healthcare Unit
May 27, 2022
Influenza Trial in Novosibirsk, Perm, Saint Petersburg (Flu-M [Inactivated split influenza vaccine], Inactivated influenza split
Completed
- Influenza
- Flu-M [Inactivated split influenza vaccine]
- Inactivated influenza split vaccine
-
Novosibirsk, Russian Federation
- +2 more
Mar 16, 2022
Tuberculosis, Skin Tests Trial in Saint Petersburg (Mycobacterial recombinant allergens 0.1 µg, Mycobacterial recombinant
Completed
- Tuberculosis
- Skin Tests
- Mycobacterial recombinant allergens 0.1 μg
- +2 more
-
Saint Petersburg, Russian FederationLimited Liability Company "Scientific Research Center Eco-Safety
May 31, 2022
Influenza Trial in Panama (CVSQIV)
Recruiting
- Influenza
- CVSQIV
-
Panama, Calidonia, Panama City, Panama
- +2 more
Mar 10, 2022
Influenza Trial in Perm (Inactivated Split Influenza Vaccine, Placebo)
Completed
- Influenza
- Inactivated Split Influenza Vaccine
- Placebo
-
Perm, Russian FederationPerm State Medical University named after academician E.A. Wagne
Dec 16, 2021
Malaria Trial in Lambaréné (Vaccine AnAPN1)
Not yet recruiting
- Malaria
- Vaccine AnAPN1
-
Lambaréné, Moyen- Ogooué, GabonCentre de Recherches Médicales de Lammbaréné
Jun 21, 2023
Covid19 Trial in Hong Kong (Tozinameran, CoronaVac, CoronaVac, intradermal)
Active, not recruiting
- Covid19
- Tozinameran
- +2 more
-
Hong Kong, Hong Kong, ChinaQueen Mary Hospital
Jul 14, 2022
Influenza, Human, Vaccination; Infection, Vaccines Trial in Russian Federation (Flu-M, Inactivated split influenza vaccine,
Completed
- Influenza, Human
- +2 more
- Flu-M, Inactivated split influenza vaccine
- Ultrix®, Inactivated Split Influenza Vaccine
-
Barnaul, Altai Territory, Russian Federation
- +4 more
Jul 11, 2022
Norovirus Acute Gastroenteritis Trial in United States (mRNA-1403, mRNA-1405, Placebo)
Not yet recruiting
- Norovirus Acute Gastroenteritis
- mRNA-1403
- +2 more
-
Long Beach, California
- +14 more
Aug 7, 2023
Respiratory Syncytial Virus Infections Trial in Missoula, Norfolk (RSV MAT)
Withdrawn
- Respiratory Syncytial Virus Infections
- RSV MAT
-
Missoula, Montana
- +1 more
Mar 31, 2022
SARS-CoV-2 Trial in Salvador (Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine, Cohort 2 RNA VACCINE MCTI CIMATEC
Recruiting
- SARS-CoV-2
- Cohort 1 VACCINE RNA MCTI CIMATEC HDT (HDT-301) vaccine
- +3 more
-
Salvador, Bahia, BrazilHospital da Bahia
Mar 23, 2022
COVID-19 Trial in Melbourne (Bivalent Moderna, Novavax)
Not yet recruiting
- COVID-19
- Bivalent Moderna
- Novavax
-
Melbourne, Victoria, AustraliaRoyal Children's Hospital, Murdoch Children's Research Institute
Jan 23, 2023
Coronavirus Trial in Bangkok (Baiya SARS-CoV-2 Vax 1)
Active, not recruiting
- Coronavirus
- Baiya SARS-CoV-2 Vax 1
-
Bangkok, Thailand
- +1 more
Feb 7, 2022
Influenza Prevention Trial in Lenexa, Metairie, Cincinnati (INFLUENZA G1 mHA, Placebo, Al(OH)3)
Recruiting
- Influenza Prevention
- INFLUENZA G1 mHA
- +2 more
-
Lenexa, Kansas
- +2 more
Jun 5, 2023
![](/image/sponsor/federal_budgetary_research_institution_state_research_center_of_virology_and_biotechnology_"vector")
Covid19 Trial in Koltsovo (EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19), Placebo
Completed
- Covid19
- EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)
- Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)
-
Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Institution of Healthcare "Medical and S
Mar 15, 2022